����DDS����� �������������������BNCT�
��!"#�$%&
'()*+*+
2
,-.$��/0
12DDS���3��45
,678
���
9:;<=>�?@AB
�������C-,DE5
FGHIJKLM=
FGHNOPQRSTO?@AB
FGHMIUB�
�V
-,DQRFGHWXMIUB�
T 67YZ67YZ67
FGHNOP�[\��]^
-,D�_`a/03,bc�]^C
deafgRhSTOijkgR
ilmknobc�]^50%pq�
-rsD/0tu4
vwFGHxy40 ppmpqvT/B>10tu4
vz��{|tXmk}~rs����i4�
v��w������S������i4�
v-rsD3����������_�100%
3
���������������
��FGHNOP���w�����FGHxyr��$�������� �����_h¡¢£¤¥�_`r¦§
¨©�ª«:¬@>���®¯K°h.�h±²±h³´±hµ¶·±�
1� �����¸¹�º»t¼½¾¿FGHNOP�¿¼�DDStÀ�¾¿
��FGH[\��]^
wFGHxy>40 ppm �ÁÂ����ÃÄÅ�T/B>10 �BSH��1-1.5hBPA��3-4�
2��ÆÇ�ÈÉ3¾Ê�ËÌÍNDDS �-,D�_`a/0ÍtXmk?@ABh
9:;<=>�tXmk?@AB����
B-1: FGHIJKLM=B-2:FGHWX�DDSÏD
�����ijÐQR-,D�50Ñpqr/0ÒÓk
9:;<=>Î��Ôk67TOÕÖ×�t��¾h�������!h��Ø�ijÐ50%pq�ÙG�rÚÛ
C-1:-,D�MMB�Ü=>«BJC-2:9:;<=>�67TOÕÖ×�
4
vvw�FGHxy40 ppmpq�ÁÂ���¸¹�ÃÄÅ�vw3ÝÞ��FGHxy�ß T/B>10�àá��âÄ�
ÃÄÅ
u4wã
B-1:FGHIJKLM= B-2:FGHWX�DDSÏD���äå
��¾¿DDSt�æ¿,¤çÙG����
èé,67êFGHIJKLM=hHVJ-E, HVJ-MIUB�hFGHMIUB�rèé,67i
ëæÊ67wFGHxy40 ppmpqtu4
ÙG�ìêHVJ-E(BSH)�íØ����FGHxy40 ppmpq, T/B>10tu4FGHMIUB��áî���T/B>10tu4 (FGHxy�13.4 ppm �
vïðñWXñòó*ô���w��!�������������_tu4vFGHMIUB��áî��!������ijÐ{õ,�ö÷høùÙG��úû�Xüfýþtu4
5
FFGH�iFG�t��¾¿IJKLM=�FGHNOP
ï��*�ô�ïï*�ô�tFGHgRD3¾¿IJKLM=�FGHNOP
4-Boronophenylalanine Ethylester(BPA-OEt)
4-Boronobenzylcysteine Ethylester(BBC-OEt)
NH N
HNN
NHHN O O
HO NO
O
NaOONa
O
10BHO OH
10BHOOH
NH N
HNN
NHHN O O
HO NO
O
NaOONa
O S
10BHO OH
S
10BHOOHEC-028 EC-031
10B
COOEt
HO
OH
NH2 10B
SHO
OH
COOEt
NH2
��.� P. 98B-1:FGHIJKLM=���
6
FFGH.�� Jß�]±FGH�i�*�J�=t��¾¿IJKLM=�FGHNOP
IJKLM={O��i�J�� J�tgR¾¿FGHNOP
4-Carboran-1-ylmethoxybenzoic acid (CMBA)
OC
HC
OH
O
: nBH
NH N
HNN
NN O O
HO NOHN
O
ONa
O
ONaOONa
O
O
NaO
O C
HC
: nBH
EC-032
��.� P. 100
7
��67ië�kFGHIJKLM=EC031, EC032���È�
��.� P. 103
8������������ ���
���� ��������������
� � ����������������
�����
FGHIJKLM=EC031(b�ue), EC032(red) �67wxy����N
67wFGHWX���g/108 cell)�
�>�67�U251:73.8 ppm
��.� P. 104
��.� P. 105
9
FFGHNOPQRHVJ-Envelope (HVJ-E) Vector���
���?@ABr� !Í
B-2:FGHWX�DDSÏD���
"ï
ñ#$%&'()**
����Pilot plant����
���� !
�+ �,+STOijk-.gR
T 67YZ67YZ67
-bc�/�N�
04211i,���¿¼�����i¤Â23
-Nucleocapsid, -Polymerase
HVJ-E (Empty vector)Wild type HVJ HVJ-E (+BSH)HN
F
Nucleocapsid(RNA, NP)
M
HVJPolymerase
(P, L)
45V
CÆ6/�DC¡7
SH
BSHSH
BSH
��.� P.127
HVJ-E��89:ê;<=>?@A�4BCÉ(�DEêFGàH�
10
Inactivation BSHLipid mixture
HVJ-liposome
Liposome with boronated compound
HVJ
SH
BSH
HVJ-liposome�I��89:ê9JM��4BCÉ(�DEêKaneda, Y., Dzau, VJ�
11
0
20
40
60
10 12 14 16
Added B (ug)Cel
l B c
once
ntra
tion
(ug
/g)
CT26 LM8
BSH delivery to cancer cells by HVJ-liposome
KL�rs67i40 ppmtMNkFGHxy�[\r!Í(HVJ-E�OPQ�
BSH�RS���TOU 0.12 – 0.18 Vg/107cells (4.8-7.2ppm)
��.� P. 131
12
W#$�X'ï'(�&()&YX%YZ�&
,
+,
[,
),
\,
],,
]+,
][,
]),
, ^ ], ]^ +, +^ _,
`Xa'%bY)X'ï'%c$Z&
ï'#ded'Y#$�X
Zfgf
Zfhf
ñòó'ZfYf
BSHQRHVJ-E�íØ���80 �g 10B/HVJ-E/tumor �
CT26��FGHxy
BSH �80 �g 10B��ìi�íØ��wxy:12-27 ppm
�xyê86.4 ppm(75.8 ppm at 1hr, 93.5 ppm at 1.5 hr)
��.� P. 133
13
ï*��c'j�X�&'(�&()&YX%YZ�&
,f,
+f,
[f,
)f,
\f,
],f,
]+f,
, ^ ], ]^ +, +^ _,
`Xa'%bY)X'ï'%c$Z&f
ï'#ded'k`�*)'j*��c
Zfgf
Zh
ñòó'ZfYf
CT26ìi�BSHQRHVJ-E�íØ��!�Ý�FGHxy
� ÝÞ�xyê0.5 ppm�
HVJ-E�íØ��!�Ý�xyê0.5 ppm
BSH�íØ��!�Ý�xyê0.6 – 1.1 ppm2000 �g 10B/body �lmw��24�n!�Ý�xyê0.6 ppm
��.� P. 133
14
��>���S��t�Si��¾¿ÙG�iñòó*ôeïðñt��w��!h�����
ijÐoDf�_rpqk
PBSPBS BSHBSH HVJHVJ--EE
ì
{|
��.� P. 161
15
FFGHMIUB����
double tail
H. Nakamura, Y. Miyajima, T. Takei, S. Kasaoka, K. Maruyama, Chem. Commun. (Hot paper) 2004, 1910.
hydrophilic part
rs��J�=tu�À��XÌO4qvæwm濼xyai�æ ÓÊz¿FGH@�AB�
ý{E5�| Ó¿rh�ö÷�| Óf�}¿~ý{E5�| Ó¿rh�ö÷�| Óf�}¿~FGHxy�FGHxy�7.2 mg/kg7.2 mg/kgr�����Æhr�����Æh14.4mg/kg14.4mg/kg������r| Ó¿~������r| Ó¿~
NaH
O OOH
B-2:FGHWX�DDSÏD���
�1��FGHMIUB������
16
n = 16: Stearoyln = 14: Parmitoyln = 12: Myristoyl
O NH
O
OO
O
H3C(H2C)n
O
H3C(H2C)n
S
2-O
M=�B����R
DMCBL (n = 12)DPCBL (n = 14)DSCBL (n = 16)
OS
O
OO
O
H3C(H2C)n
O
H3C(H2C)n
2-
DMBL (n = 12)DPBL (n = 14)DSBL (n = 16)
O Y
OS
2-
BC (Y = CH2)BCC (Y = NHCOCH2)
����FGHMIUB��$���
jÐ���jÐ����FGH.��WX��±zæ�FGH.��WX��±zæBSHBSHFGH@�AB�À�FGH@�AB�À�
BB1212HH1212SH (BSH)SH (BSH)
SH
2
--
Liposomes consist of phospholipids and cholesterol
(9�ê2006-186907h2006-275367h2006-259290�
��.� P. 108
17
% c
ell g
rowt
h
DM
BL
100.
00 p
pmD
MB
L 33
.33
ppm
DM
BL
11.1
1 pp
mD
MB
L
3.70
ppm
DM
BL
1.23
ppm
cont
rol
DPB
L10
0.00
ppm
DPB
L 33
.33
ppm
DPB
L 11
.11
ppm
DPB
L 3.
70 p
pmD
PBL
1.23
ppm
DSB
L
100.
00 p
pmD
SBL
33
.33
ppm
DSB
L
11.1
1 pp
mD
SBL
3.
70 p
pmD
SBL
1.
23 p
pm
DM
CB
L 1
00.0
0 pp
mD
MC
BL
33
.33
ppm
DM
CB
L
11.1
1 pp
mD
MC
BL
3
.70
ppm
DM
CB
L
1.2
3 pp
m
DPC
BL
100
.00
ppm
DPC
BL
3
3.33
ppm
DPC
BL
1
1.11
ppm
DPC
BL
3.70
ppm
DPC
BL
1.23
ppm
DSC
BL
100
.00
ppm
DSC
BL
3
3.33
ppm
DSC
BL
1
1.11
ppm
DSC
BL
3.70
ppm
DSC
BL
1.23
ppm
BSH
100.
00 p
pmB
SH
33
.33
ppm
BSH
11.1
1 pp
mB
SH
3.70
ppm
BSH
1.
23 p
pm
B(O
H)3
100.
00 p
pmB
(OH
)333
.33
ppm
B(O
H)3
11.1
1 pp
mB
(OH
)33.
70 p
pmB
(OH
)31.
23 p
pm
BC
100.
00 p
pmB
C33
.33
ppm
BC
11.1
1 pp
mB
C3.
70 p
pmB
C1.
23 p
pm
667�?J��ï�WE5
��'"%a`
"%a`
��.� P.110
18
ï* *Zh�a�$)���ï�^,�
]f,
],f,
],,f,
],,,f,
, + [ ) \ ], ]+ ][ ]) ]\
c%�a'%bY)X'ZXX%cZ%YZ�&
Y#$�X'g�*#$)'�$$_�
50%DPBL (5 mg 10B/kg)MIUB�t�æ¿BNCT���E5
Mice died.
Tumor disappeared!
control
DPBL(50%) Liposomes(5 mg10B/kg)
BSH (57 mg10B/kg)
PEGPEG--DPBL(50%)DPBL(50%)FGHMIUB��FGHMIUB������jÐ�xy�������rö÷jÐ�xy�������rö÷
�������ý{r�Æ�}¿��������ý{r�Æ�}¿�
ÙG�{õ,CT2667tÙG�����i¤çFGHPEGMIUB��5 mg 10B/����lm��h24hr!������30$�
�����V� �1.0 x 1012 n/cm2
19
FGHMIUB��ÙG�ilmk��ëjù����n!���wFGH���úxy
������������������������
������������������ �������
������������������������
������ �������������������
������������������� ����������
����������� ������������
����
��
����� ��
��������
�������
�������
�������
������
�������
�� ������
���
���
����
���
����
���
��
���
�����
� !
��
��
�
��
�
��
��
��
"#$%&
'(��)��*)�
�������
� ������������
��������� ��
�������� �������
����������
����������������
������������
�������� ��
+,-,
���./01�
2� ������34!"#$��
��.� P. 111
20
0.600.44
8.817.60.69
24h!�FGH�\�
à3�È�hXE�È�hàá�È��{5h25% or 50% DSBL (10-20 mg B/kg)tin vivo� ¡mkq3i¢3
£MIUB��£~¤wFGH$¥
DSBLê 50% 25%wê13.4ppm 22.6ppmÝÞ�ê0.76ppm 37.6ppm
��.� P. 111
21
,f,
],,f,
+,,f,
_,,f,
[,,f,
^,,f,
),,f,
¦,,f,
\,,f,
§,,f,
, + [ ) \ ], ]+ ][
�ðï�'+[`'+,$dïe¨d
(�&YX�*'`�Y
ñòó*�ðï�'^$dïe¨d
W©'+[`'+,$dïe¨d
+^ª�ðï�MIUB�øùñòó*FGHMIUB�t�æ¿ï�Wijk-E5 ¡
Tumor shrinkage
PEG
��!�;L
�\
��.� P. 113
22
,
],
+,
_,
[,
^,
),
¦,
\,
§,
],,
, ^ ], ]^ +, +^ _, _^ [,
�ðï��+^ª�`�Y
(�&YX�**(�*c
�ðï��^,ª�`�Y
ñòóô*�ðï�'
«¬®!�¯rsÙG���úû
�����V� ,f§*]f['°'],]+ &e($+ ±V� ]f¦*+f]'²�
10mg10B/kg >42 days
0³´{ 8 days
5mg10B/kg
DSBL-FGHMIUB��XE�hHVJ-FGHMIUB��]^E5�¡D
��11��FGHMIUB�����FGHMIUB���ý{E5ý{E5�É~�É~�ö÷�| Óf�}¿~�ö÷�| Óf�}¿~
FGHxy�FGHxy�7.2 mg/kg7.2 mg/kgr�����Æhr�����Æh14.4mg/kg14.4mg/kg������r| Ó¿~������r| Ó¿~
Bioconjugate Chem. 2006, 17, 1310.
��.� P. 114
23
FGHNOP�wxy3T/Bß
HVJ-E(BSH)��ìi�íØ��� 32mg 10B/kg �ÙG�{õ,ê�xyê86.4 ppm, ÝÞ�xyê0.5 ppmÙG�µ0q�,ê�xyê135 ppm, ÝÞ�xyê0.5 ppmwFGHxy40ppmpq, T/B>10tu4BSH�ÙG�{õ,ìi�íØ��wxy:12-27 ppmhÝÞ�xyê0.6-1.1 ppm
�2��FGHMIUB��ÙG�{õ, ¶Ji�áî��20mg 10B/kg ��24�n!�wxyê13.4 ppm, T/B=17.6T/B>10tu4
��?@AB�ÙG�{õ, ¶Ji���� >40ppm, T/B>10 �u4�!Í��1���FGHMIUB�(Bioconjugate Chem. 17, 1314-20, 2006)7.2mg 10B/kg ��24�n!�wxyê23.1 ppm, T/B=2.3BSHQRTf-PEG-liposome (J. Control. Release 98, 195-207, 2004)35 mg 10B/kg ��72�n!�wxyê33.1ppm, T/B=6.0BSHQRPEG-liposome (J. Control. Release 98, 197-205, 2004)35 mg 10B/kg ��72�n!�wxyê24.3ppm, T/B=2.5
24
vv�����ijÐQR-,Dr50%pq/0ÒÓkv�������!h��Ø�ijÐ50%pq�ÙG�rÚÛ
ÃÄ
u4wã
C-1:-,D�MMB�Ü=>«BJC-2:9:;<=>�67TOÕÖ×�
���äå
vïððïtQR¾Ê�����mk3QR-rsD�§,ªpq�MMB�i4�v9:;<=>Î��Ôk67TO?@AB���i4�¾¿rhq�?@ABt�æ¿ï�Wijk��!h����_i·æÊ�h23¾¿��r��¸¹�º»�¿¼¼Â�zf�}¿~
¨!�lIvó½½*[�.�¾r¿À��h��t�Á�zkZÂ�Ôk~ÃĶBA3¾Êh-rsD39:;<=>�67TO×��ÅÆ,w{õ,t��¾hÇÈÙG�i67t�Ø�mk3ÚÛ�],,ª�Ô}¿��h45rÉÊÒÓk~
��E5vFGHNOPWXPEG-CG-HVJ-E�áî��ijÐ}~iz��{|t
XmkÙG����i4�
25
�4$MIUB��Ë100 nm��XV$È�3��Ì4�ÍÎÏÐ/�VÑÒ�âÄ�IRSI� � kirrad / kcont �Ó�íÔ
q�Ô¿Ð�Ì4ßrÕO/�V�ÖÓwmæ~
XChol
X DLO
PC XDSPC
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0
0.1
0.2
0.3
0.4
0.5
0.7
0.6
0.8
0.9
1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
OO
OO O P O
O O-N+
H H
Dilinoleoyl phosphatidylcholine(DLOPC)
OO
OO O P O
O O-N+
Distearoyl phosphatidylcholine(DSPC)
HO
H
H
H
Cholesterol (Chol)
�æ¿��� ×Ô�à3
MIUB�×4�ÍØÙ
Akamatsu, K., Effect of ionizing radiation on membrane permeability of liposome: the dependency of lipid composition, concentration, and radiation dose/dose-rate, Chem. Phys. Lipids, to be published.
��.� P. 116
C-1: �����ÁÚtÀ�¾¿-,D�Ü=>«BJMMB����
26
0
20
40
60
80
100
0 5 10 15 20 25Time for incubation (h)
Effl
ux (%
)
Û�����ijkFGH��WMIUB� �DLOPC: DSPC: BC: Chol = 20: 20: 20: 40 �Ó�høùDLOPC: DSBL: Chol = 20: 20: 60 �Ü��/ M=�ÝÞßàÞ�pH 7.4�� �-
,D�J�ªá=�/0����Ü=>«BJ�£âãhä�åæ�~MIUB�çèÞxyê),'$éh],ïxyê],,,'hh$~
DLOPCt@NÊOFGHMIUB��������êÖÒÓfæ
-,D
10BWX��10B 10B
10B
10B10B
10B10B
10B
SO
O
H
H
H
S
O
OOC17H35
O
C17H35
OBC DSBL
«ê«ëì3Chol�{O�íë«+êíëîQ�«ëìWXïð��
��.� P. 123
27
MIUB�w�iïðñ3(%Xj�h*%YZ&tQRmk
À�ê10BñÖ��ò¿4He, 7Li×��hóôMIUB�Stõö¾Êæ÷~
���êø carboplatin�BSH3ùI¾Êúâi�/�N�ûü�mk~ý BSHxyrËæ3MIUB��Î4r¦§
(%Xj�h*%YZ&3þú�zk�N�ïðñ�ïððï��O4
B SHH2O2
2 Na+
: BH
2 Na+
B S BS
2 Na+
~ pH 11
28
ïððïQRMIUB��Û���ÑÒ�tO·v Û���K�@�ê 1.64 x 109 n/cm2/s
v ���nê 4�n
v ��É��xyê ~ 10 mM
v çèÞw0³10B: 226 ppm
v çèÞw0³Ptxyê 8 ppm
Pt
Pt
Pt
PtPt
Pt
vMIUB�Ì4êDLOPC: DSPC: Chol = 2: 2: 6
Carboplatin
BSSB�10BFGHNOP�
/0
û�Ñ
�
0.9 % NaCl
�� �h9�2008-041048�ÏÐ/�V$È�MIUB�h�Ót�æ¿MIUB�ÏDhùiMIUB����� Akamatsu, K., Development of thermal neutron- sensitive liposome for a novel drug delivery system aiming for radio-chemo- concurrent cancer therapy, Radiat. Phys. Chem., to be published.
,
+,
[,
),
\,
],,
ïððïQRf¾���
ïððïQRf¾��
ïððïQRÔÐ���
ïððïQRÔÐ��
=�;?B>�
_¦�h[�n
ÏÐ/�VhÛ���ÑÒ��MIUB����øù��ijk-rsD�Ü=>«BJMMB���ÆÇ
��.� P. 125
29
C-2��9:;<=>�67TOÕÖ×����
*
N.S.
0
100
200
300
400
500
600
700
800
900
1000
0 5 10 15 20 25
Days after tumor inoculation
HVJ-E
AdVSaline
Suppression of CT26 growth in vivo by HVJ-E�Kurooka, M, Kaneda, Y: Cancer Research, 2008.�
Tumor-free mice
0
10
20
30
40
50
60
70
80
90
100:1 50::1 25:1 12.5:1 6:1 3:1
ET ratio
67���T 67��g
HVJ-E
Control
��.� P. 162
�200711�3;��1���16����
300
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 5 10 15 20
Days after inoculation
HVJ-Eijk.�¥��ijÐùl������r�_
*
HVJ-E or saline injection into the right flank tumor
CT26 inoculationin the right flank
Day -4 Day 0 Day 4 Day 8
CT26 inoculationin the left flank
HVJ-E or saline injection into the right flank tumor
HVJ-E or saline injection into the right flank tumor
Monitor tumor formationat the left side
Rat
io o
f tum
or-f
ree
mou
se ��Ñ�ÙG��ö÷
31
HVJ-E
YZ67
NK
T 67
IFN-�,-�
NFkB
IL-6IFN-�,-�
Reg. T
NK67�/�N _`�T 67��_
,678
YZ67�/�N
CTL��g
HVJ-Eijk-J�r��
IFN-�?
��.� P.164
32
(A) Rantes
(B) IFN-��
(C) IL-12
©�*%'�hde$*�
,+,
[,),
\,],,
]+,
�*� WXZY�&',f] Wk\,',f,] Wk\,',f,+ Wk\,',f,^ Wk\,',f]
ñòó*ô
©�*%'�hde$*�
�*]+
*],
,
],
+,
_,
[,
�*� WXZY�&',f] Wk\,',f,] Wk\,',f,+ Wk\,',f,^ Wk\,',f]
ñòó*ô
�*]+'�hde$*�
½%&Y)a
*],,
,
],,
+,,
_,,
[,,
^,,
�*� WXZY�&',f] Wk\,',f,^ Wk\,',f] Wk\,',f+ Wk\,',f[
ñòó*ô
½%&Y)a'�hde$*�
HVJ-Eijk! >� =h® � =�g�QRi�ækDetergent�¸¹ij}Ê_`!Í
33
siRNA
Tf-F
Wild HVJ
HN (-)/Tf-F (+)HVJ
HN mRNA
HN-mRNAdegradation
Äa$�tX¾HNt"#¾¿ÄagRHVJ-E���J. Biotechnology 2008, BBRC, 2007, Human Gene Ther. 2007
Tf-Fstable transformant,
,f+
,f[
,f)
,f\
]
]f+
]f[
]f)
&�X$%* a(X%$j*) ñ�*aZ½��
X)*%YZg)'X%YZ�
Hemagglutinating Activity Assay
HN
Cont. SiRNA
F
HN"#3�Ý$%[��_
��.� P.148
��.� P. 145
(200718�5;�;1�������
34
HEK293(Low TfR) HeLa (High TfR)
Tumor-specific infection of HN-depleted targeting HVJ
HN-depleted HVJ with Tf-F
HN-depleted HVJ
Wb*© (`Z$)X%
©
��.� P. 149
35
Tf-F HVJ-E chimera HVJ-E
,
],
+,
_,
[,
^,
),
¦,
\,
§,
kZ**c (`Z$)X%
Y�Y%*'
&c�Y
Q-dotQRTf-F�JHVJ-E���ÄaÍ� '
�lmw��!48�n�
¨!�Tfi�(kÄa$�t�æk
Tf-F HVJ-EijkQ-dot���w$¥
��Ì)h}~iPÝi 0��*�oåÌ)i� 0ÒÓô
Wild HVJ-E��+�~¤iO 0ÒÓô
��.� P. 150
36
CC NNOO
NHNH22
NHNH22
Cationized Gelatin ( CG)HVJ-E
+
CG-HVJ-E
�á,=N-á=./HVJ-Eijkw0P1u
,
],,,
+,,,
_,,,
[,,,
^,,,
),,,
¦,,,
\,,,
§,,,
ñòó*ô ñòó*ô2²
*�$h`f
*#&d
*Zg)X
ah*))&
Tumor nodule
Liver Spleen
HVJ-E CG-HVJ-E
3�i{|t4·ÙG�
Intraperitonealinjection
�J. Gene Medicine, 7, 888-897, 2005) ��.� P.152
37
,^,,,,],,,,,]^,,,,+,,,,,+^,,,,_,,,,,_^,,,,
²*ñ
òó*ô
�X)Z$
$#&)
�&YZ*©'�j'�°]�
�&YZ*©'�j'�°[�
"�XY$
%&&Z&'̂,
"�XY$
%&&Z&'+^
�#(Zb)X%a)'%(YZgZY�'�½�
5�
CG-HVJ-Eijk67��Á�
TO89ilmk-���:;tmk3�_ÒÓkrh<=s! >B �=�D��>3s+�_ÒÓfæ
38
56�7689:;<;=>?@AB
0102030405060708090
100
0 10 20 30 40 50 60 70 80 90 100
?@C/
?@D
EF GF HF EF GF HF GF HF
ÙG���úû
Day
Surv
ival
Rat
io (%
)
PBS BLM CG/BLMHVJ-E/BLM
CG-HVJ-ECG-HVJ-E/BLM
CG-HVJ-E/BLM
BleomycinQRHVJ-E�3�w��ijk3S��,�����
(Mima, H., et al. and Kaneda, Y.: Mol. Cancer Ther. 2006)
38
39
Control Mice Survived Mice�Mol. Cancer Therapy, 2006)
IJKCT26LMNOPQ
×4: 0/4×4: 3/3
39
40
DXR DXR/HVJ-E
2/6 (33%) 0/10 (0%)Tumor
��úÙG�ÅÆi��Ø�
-rsDCHVJ-EijÐ��!�ÙG�i��Ø�
�%�', �
ÅÆ,67�?«�@�¤ç
ñòó*ôCs�UJA =s�UJA =RD
(Cancer Chemother. Pharmacol., 2008)
BC�ÅÆ, ¶Jië�k��E5
2/2
0/2
Tumor
Naive
HVJ-E/BLMtreated
�%�',
{õ,67�W+)�¤ç
D E �� ��
ñòó*ôvï�é�w�����3�w�
{õ,�� ¶Jië�k��E5
�BMC Medicine., 2008)
��.� P. 165
41
PEG{{O�á,=N-á=./HVJ-ECH2
NH
C
NH
(CH2)3
N:H+Cl-
CH3
H3C
O
CH3
++ ++ ++
gelatingelatin(IEP=9.0)(IEP=9.0)
EDCEDC(1(1--ethylethyl--33--(3(3--dimethylaminopropyl)dimethylaminopropyl)--
carbodiimidecarbodiimide,, hydrochroridehydrochroride))
EthylenediamineEthylenediamine cationizedcationized gelatingelatin
CH3
CH2
NH
CH
N
(CH2)3
N:H+Cl-
CH3
H3C
NH2
CH2
CH2
NH2
NH2
CO
OH
NH2
C
O
NH
CH2
CH2
NH2
37 O C
pH 5
HVJ-EPEG
PEG-CG-HVJ-E
9�2007-157701,���A�@Jøù��Ï���ùi�Ót�æ¿ÏD(�DEêFGàHhFGHhIJKL �<M9:0�NONo. 12/054,200
42
}}£¤ ¶Jilmk12DDSt�æ¿BNCT
LM8G5�ÙG�tP67�7�w��14;!
ÙG�}~��z��{|
FGHNOPQR?@AB�áî��
Neutron
Boron compound(BSH)
SH
BSH
HVJ-E
SH
BSH
PEG./
�á,=N-á=
43
}}£¤ ¶Jië�kFGHQR?@ABáî��!hï�Wijk��E5
Liver Weight (g)
0 1 2 3 4
PEG-CGHVJ-E
CGHA-HVJ-E
CG-HVJ-E
HVJ-E
BSH
normal liver
BNCT(-)
Control Normal Liver BSH
HVJ-E CG-HVJ-E PEG-CG-HVJ-E
10B concentration:BSH; 1,000 �gB/ headHVJ-E BSH, Polymer HVJ-E BSH; 13.6 �gB, 1,500 HAU/head
(QRÎ4��
��.� P. 160
44
FFGHNOPgR!�}~Ì)t�����¾h9JK°BV�s�>t 0
Tumor
NormalLiver
BSH 750 �gB BSH 30 �g B PEG-CG-HVJ-E BSH 25 �gB
45
BSHQQRPEG-CG-HVJ-E t�æ¿BNCT��!�S,ÙG�}~Ì)
Normal Liver
Tumor
zL�M=T$�UV
4646
�����45i·æÊ
[\��ËæFGHDDSÏD���
-rsD�Ü=>«BJMMB����
ÃÄ�u4y
45�üW
XaYZ[�\]f+
45�^ø
vFGHNOPQRHVJ-E�Ì)i�
íØ��ijÐ�·�ÃÄÅt@M9vFGHMIUB��áî��ijÐT/B>10t@M9vFGHIJKLM=hBSHQRHVJ-liposome�èé,67iëæÊ67wFGHxy40 ppmpqt@M9~
v-rsD�MMB�Ü=>«BJ�ÃÄÅt@M9�zkMIUB�t��v9:;<=>�67TOÕÖ×�t��vBNCT!��Ø�����_Â
v.`�.�¾�º»�¿¼~¿ÀmÓa��t�Á�zkbc�de~v9:;<=>�67TO×�3-rsD���¾¿ÙG���Ø�!�ÚÛû�100%~
vBSH/HVJ-Et�æ¿BNCT����¦§f
���S���f1a��3fÐgk~vFGHMIUB��BNCTië�káî��
�?@ABifÐgk~vBSH/HVJ-E, FGHMIUB�th�mÓa
Ô ikj×rs���lÚ3fÐgk~v,a�Ð�f÷Ýk�lmwÍ|MGÙáf+���iOXE�rËæ3ÄN Ók~
v-rsD�Ü=>«BJMMB�MIUB���ÆÇ~qÓ�ÏÐ/�ViOÑÒ�rÔÐ/�V��áyin��rÔk~v9:;<=>�67TOÕÖ×���ÆÇ~*�?@AB��q�jgfÌÍ�X¾fæ~qÓijÐ,�¡¢£¤¥��_w������ ��rsO�_�zh�·,�2oO!ÍifÐhàáà7f�/��Ái�pq±~
Mw0�9:D¹�Mr0�1¹��FGHMIUB�3¹h���vÏÐ/�VÑÒ�MIUB�h,���A�@J�
vQR�å�h=Rs�QR44t�s�f¾16t�huv11tvµ&�å�Mw81¹hM523¹v1��å�5¹(FGHMIUB�3BNCTr3¹hÄaNHVJ-E, 9:;<=>E5)
47
DDSÏÏD���N�|õ¾
HVJ-E��BTB9w���� B�id0�;NO�D�
20091 20101 20151 20201
FGHMIUB�
IMÙBHVJ-E
RD������ RD���� �:¬Ö¯¶L9x�
GLP����
��������,��������S��hy�z{h
{õ,�}£¤f+
���ÏDÏ���|B
GLP�����������ijk,�������
FGHIJKLM=
BSH�� ���K°BÙx�y�z{GLP���È�